BDBM285568 N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US10077269, Example 41::US10669279, Example 41::US9598421, Example 41

SMILES Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1

InChI Key InChIKey=XXAZCHDKOQBDMG-UHFFFAOYSA-N

Data  12 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 285568   

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 3.13nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 8.05nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 16.8nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 467nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 3.13nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 8.05nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 16.8nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 467nMMore data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 3.13nMAssay Description:Human PDE4A3 coding sequence (amino acids 2 to 825 from the sequence with accession number NP_001104779) was cloned into the baculovirus expression v...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 8.05nMAssay Description:Human PDE4A3 coding sequence (amino acids 2 to 825 from the sequence with accession number NP_001104779) was cloned into the baculovirus expression v...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 16.8nMAssay Description:Human PDE4A3 coding sequence (amino acids 2 to 825 from the sequence with accession number NP_001104779) was cloned into the baculovirus expression v...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM285568(US10077269, Example 41 | N-cyclopropyl-3-(3-fluoro...)
Affinity DataIC50: 467nMAssay Description:Human PDE4A3 coding sequence (amino acids 2 to 825 from the sequence with accession number NP_001104779) was cloned into the baculovirus expression v...More data for this Ligand-Target Pair
In DepthDetails
US Patent